$1.84
arrow_drop_down9.99%Key Stats | |
---|---|
Open | $2.06 |
Prev. Close | $2.05 |
EPS | -0.69 |
Dividend | Non-Dividend |
Next Earnings Date | - |
Dividend Yield % | - |
Market Cap | $720.32M |
PE Ratio | - |
LOW | HIGH | |
---|---|---|
Day Range | 1.81 | 2.16 |
52 Week Range | 1.21 | 3.04 |
Ratios | |
---|---|
EPS | -0.69 |
Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.
Period: Next 12 Months
•Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.
Standard BioTools Appoints Alex Kim as Chief Financial Officer
Standard BioTools Announces Conference Call and Webcast for Third Quarter 2024 Financial Results on October 30, 2024
Labrador Gold Shareholders Approve Sale of Kingsway Project
5 Medical Info Systems Stock to Buy for a Stable Portfolio
Standard BioTools Purchases the Carterra® LSA-XT System to Accelerate Data Delivery and Provide Greater Validation to SomaScan Customers
Labrador Gold Provides Update on Sale of Kingsway Project